RRM2 and neoplasm: The analysis of the expression of RRM2, CDC6, and TOP2A in normal and tumour breast invasive carcinoma using GEPIA showed significant increased expression of RRM2, CDC6 and TOP2A in tumour samples as compared to normal tissue (Fig. 7A).